October 20, 2021 Fusion Pharmaceuticals Announces Presentation Of Preclinical Data Supporting Its FPI-1966 And FPI-2059 Targeted Alpha Therapies
October 19, 2021 Germany is world’s first country to cover digital therapeutic for Burnout through universal reimbursement – free access for 50 million adults
October 19, 2021 Nordic Nanovector enters research collaboration with the University of Pennsylvania to generate a novel CD37-targeting CAR-T cell approach
October 12, 2021 Lakeside is the first healthcare provider in the UK to go live with the Doctrin platform – the second generation of digital healthcare systems from the Swedish healthtech company Doctrin
October 06, 2021 Precirix dosed first patients in Phase I/II clinical study evaluating CAM-H2 in HER2-positive metastatic cancer
October 05, 2021 Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.